A Novel PMVK Variant Associated with Familial Porokeratosis

Background: Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including phosphomevalonate kinase (PMVK) may alter this pathway, ultimately leading to porokeratosis. Objectives: The aim of the study was to i...

Full description

Saved in:
Bibliographic Details
Published inHuman heredity Vol. 88; no. 1; pp. 50 - 57
Main Authors Zhang, Wenjing, Nie, Xinmiao, Shi, Lei, Shao, Fengmin, Cao, Lihua
Format Journal Article
LanguageEnglish
Published Basel, Switzerland S. Karger AG 01.01.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including phosphomevalonate kinase (PMVK) may alter this pathway, ultimately leading to porokeratosis. Objectives: The aim of the study was to identify the causative gene variant of porokeratosis in a Chinese family and investigate its population frequency and pathogenicity. Method: In this study, Sanger sequencing was used to identify the gene variant causative of porokeratosis; its population frequency was investigated by polymerase chain reaction-restriction fragment length polymorphism in 4 patients and three normal individuals as well as in 100 normal unrelated controls; finally, the pathogenicity of the mutation and the associated structural changes were predicted. Results: We identified a novel heterozygous missense variant, c.207G>T (p. Lys69Asn) in the PMVK gene. This variant was found in all patients but not in the normal individuals in this family or in the 100 controls. In silico analysis indicated that the variant was pathogenic; p.Lys69Asn changed the length of the α-helix and the hydrogen bond pattern compared with the wild-type protein. Conclusions: The novel variant c.207G>T (p. Lys69Asn) in the PMVK gene was the causative variant in this porokeratosis family. This finding provides further evidence for the genetic basis of this disease.
AbstractList Background: Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including phosphomevalonate kinase (PMVK) may alter this pathway, ultimately leading to porokeratosis. Objectives: The aim of the study was to identify the causative gene variant of porokeratosis in a Chinese family and investigate its population frequency and pathogenicity. Method: In this study, Sanger sequencing was used to identify the gene variant causative of porokeratosis; its population frequency was investigated by polymerase chain reaction-restriction fragment length polymorphism in 4 patients and three normal individuals as well as in 100 normal unrelated controls; finally, the pathogenicity of the mutation and the associated structural changes were predicted. Results: We identified a novel heterozygous missense variant, c.207G>T (p. Lys69Asn) in the PMVK gene. This variant was found in all patients but not in the normal individuals in this family or in the 100 controls. In silico analysis indicated that the variant was pathogenic; p.Lys69Asn changed the length of the α-helix and the hydrogen bond pattern compared with the wild-type protein. Conclusions: The novel variant c.207G>T (p. Lys69Asn) in the PMVK gene was the causative variant in this porokeratosis family. This finding provides further evidence for the genetic basis of this disease.
Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including phosphomevalonate kinase (PMVK) may alter this pathway, ultimately leading to porokeratosis.BACKGROUNDPorokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including phosphomevalonate kinase (PMVK) may alter this pathway, ultimately leading to porokeratosis.The aim of the study was to identify the causative gene variant of porokeratosis in a Chinese family and investigate its population frequency and pathogenicity.OBJECTIVESThe aim of the study was to identify the causative gene variant of porokeratosis in a Chinese family and investigate its population frequency and pathogenicity.In this study, Sanger sequencing was used to identify the gene variant causative of porokeratosis; its population frequency was investigated by polymerase chain reaction-restriction fragment length polymorphism in 4 patients and three normal individuals as well as in 100 normal unrelated controls; finally, the pathogenicity of the mutation and the associated structural changes were predicted.METHODIn this study, Sanger sequencing was used to identify the gene variant causative of porokeratosis; its population frequency was investigated by polymerase chain reaction-restriction fragment length polymorphism in 4 patients and three normal individuals as well as in 100 normal unrelated controls; finally, the pathogenicity of the mutation and the associated structural changes were predicted.We identified a novel heterozygous missense variant, c.207G>T (p. Lys69Asn) in the PMVK gene. This variant was found in all patients but not in the normal individuals in this family or in the 100 controls. In silico analysis indicated that the variant was pathogenic; p.Lys69Asn changed the length of the α-helix and the hydrogen bond pattern compared with the wild-type protein.RESULTSWe identified a novel heterozygous missense variant, c.207G>T (p. Lys69Asn) in the PMVK gene. This variant was found in all patients but not in the normal individuals in this family or in the 100 controls. In silico analysis indicated that the variant was pathogenic; p.Lys69Asn changed the length of the α-helix and the hydrogen bond pattern compared with the wild-type protein.The novel variant c.207G>T (p. Lys69Asn) in the PMVK gene was the causative variant in this porokeratosis family. This finding provides further evidence for the genetic basis of this disease.CONCLUSIONSThe novel variant c.207G>T (p. Lys69Asn) in the PMVK gene was the causative variant in this porokeratosis family. This finding provides further evidence for the genetic basis of this disease.
Background: Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including phosphomevalonate kinase (PMVK) may alter this pathway, ultimately leading to porokeratosis. Objectives: The aim of the study was to identify the causative gene variant of porokeratosis in a Chinese family and investigate its population frequency and pathogenicity. Method: In this study, Sanger sequencing was used to identify the gene variant causative of porokeratosis; its population frequency was investigated by polymerase chain reaction-restriction fragment length polymorphism in 4 patients and three normal individuals as well as in 100 normal unrelated controls; finally, the pathogenicity of the mutation and the associated structural changes were predicted. Results: We identified a novel heterozygous missense variant, c.207G>T (p. Lys69Asn) in the PMVK gene. This variant was found in all patients but not in the normal individuals in this family or in the 100 controls. In silico analysis indicated that the variant was pathogenic; p.Lys69Asn changed the length of the [alpha]-helix and the hydrogen bond pattern compared with the wild-type protein. Conclusions: The novel variant c.207G>T (p. Lys69Asn) in the PMVK gene was the causative variant in this porokeratosis family. This finding provides further evidence for the genetic basis of this disease. Keywords: PMVK gene, Porokeratosis, Variation, Mevalonate pathway, Phosphomevalonate kinase
Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including phosphomevalonate kinase (PMVK) may alter this pathway, ultimately leading to porokeratosis. The aim of the study was to identify the causative gene variant of porokeratosis in a Chinese family and investigate its population frequency and pathogenicity. In this study, Sanger sequencing was used to identify the gene variant causative of porokeratosis; its population frequency was investigated by polymerase chain reaction-restriction fragment length polymorphism in 4 patients and three normal individuals as well as in 100 normal unrelated controls; finally, the pathogenicity of the mutation and the associated structural changes were predicted. We identified a novel heterozygous missense variant, c.207G>T (p. Lys69Asn) in the PMVK gene. This variant was found in all patients but not in the normal individuals in this family or in the 100 controls. In silico analysis indicated that the variant was pathogenic; p.Lys69Asn changed the length of the α-helix and the hydrogen bond pattern compared with the wild-type protein. The novel variant c.207G>T (p. Lys69Asn) in the PMVK gene was the causative variant in this porokeratosis family. This finding provides further evidence for the genetic basis of this disease.
Audience Academic
Author Shao, Fengmin
Shi, Lei
Nie, Xinmiao
Cao, Lihua
Zhang, Wenjing
Author_xml – sequence: 1
  givenname: Wenjing
  surname: Zhang
  fullname: Zhang, Wenjing
– sequence: 2
  givenname: Xinmiao
  surname: Nie
  fullname: Nie, Xinmiao
– sequence: 3
  givenname: Lei
  surname: Shi
  fullname: Shi, Lei
– sequence: 4
  givenname: Fengmin
  surname: Shao
  fullname: Shao, Fengmin
  email: *Fengmin Shao, fengminshao@126.com, Lihua Cao, lhcao@cmu.edu.cn
– sequence: 5
  givenname: Lihua
  orcidid: 0000-0002-0795-0397
  surname: Cao
  fullname: Cao, Lihua
  email: *Fengmin Shao, fengminshao@126.com, Lihua Cao, lhcao@cmu.edu.cn
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37315547$$D View this record in MEDLINE/PubMed
BookMark eNpt0UtLxDAQAOAgiq6Pg3eRwl70UM2jSVs8LaKu-Dyo1zCmU422zZp0Ff-9keqCIHMImXwzhJl1sty5DgnZZvSAMVkeUkqlYIzTJTJiGRcppYovk1HMs1QqydfIeggv8VrQXKySNZELJmWWj8jRJLl279gkt1cPF8kDeAtdn0xCcMZCj1XyYfvn5BRa21iIynn3ih56F2zYJCs1NAG3fs4Ncn96cnc8TS9vzs6PJ5epEaXqU5NVMXhmSlHQWqpalgAFpVlBDTBZVKyqeYGoSngsQVGslFIGJaic8bxQYoPsDX1n3r3NMfS6tcFg00CHbh40L7jiTAnBIh0P9Aka1LarXe_BfHM9yfNccVFSEdXBPypGha01cba1jfk_BftDgfEuBI-1nnnbgv_UjOrvFejFCqLd_fnt_LHFaiF_Zx7BzgBewT-hX4BF_fjf5-n0ZBB6VtXiCwtdk1I
ContentType Journal Article
Copyright 2023 The Author(s). Published by S. Karger AG, Basel
2023 The Author(s). Published by S. Karger AG, Basel.
COPYRIGHT 2023 S. Karger AG
Copyright_xml – notice: 2023 The Author(s). Published by S. Karger AG, Basel
– notice: 2023 The Author(s). Published by S. Karger AG, Basel.
– notice: COPYRIGHT 2023 S. Karger AG
DBID M--
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
DOI 10.1159/000531120
DatabaseName Karger Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE - Academic

MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: M--
  name: Karger Open Access
  url: https://www.karger.com/OpenAccess
  sourceTypes:
    Enrichment Source
    Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1423-0062
EndPage 57
ExternalDocumentID A777623903
10_1159_000531120
37315547
531120
Genre News
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
0~B
29I
326
36B
3O.
4.4
5GY
5RE
7X7
8UI
AAYIC
ABJNI
ABPAZ
ABUWG
ACGFS
ACGOD
ACPRK
ACPSR
ADBBV
AENEX
AEYAO
AHMBA
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZPMC
AZQEC
BBNVY
BENPR
BHPHI
BPHCQ
CS3
CYUIP
DU5
DWQXO
E0A
EBS
EMB
EMOBN
F5P
FB.
FYUFA
GNUQQ
GUQSH
HCIFZ
HZ~
IAO
IGS
IHR
INH
IY7
KUZGX
L7B
M--
M1P
M2O
M2P
M7P
N9A
O1H
O9-
OK1
RKO
SV3
UJ6
.GJ
0~5
30W
34G
39C
3V.
53G
88A
88E
88I
8AO
8FE
8FH
8FI
8FJ
8FW
8G5
ABBHK
ABXSQ
ADACV
ADAGL
ADULT
AEJYH
AFFNX
AFJJK
AFKRA
AI.
AILCM
AIOBO
BVXVI
CAG
CCPQU
CGR
COF
CUY
CVF
ECM
EIF
EJD
HMCUK
ITC
JAAYA
JENOY
JKPJF
JPL
JPM
JSODD
JST
JVCUD
LK8
M0L
NPM
PQQKQ
PROAC
PSQYO
RIG
RXVBD
SA0
UKHRP
VH1
ZGI
ZXP
AAYXX
CITATION
0R~
AAKET
ABZSI
ACHQM
ZA5
7X8
ID FETCH-LOGICAL-c396t-c4d4d424c9380f56f59aa800480ca158d1df28ee69ab9a60ed666ce5a67127863
IEDL.DBID M--
ISSN 0001-5652
1423-0062
IngestDate Fri Nov 08 20:42:24 EST 2024
Fri Feb 23 00:19:39 EST 2024
Fri Feb 02 04:33:44 EST 2024
Wed Sep 18 12:52:42 EDT 2024
Sat Nov 02 12:28:02 EDT 2024
Thu Aug 29 12:04:36 EDT 2024
Thu Sep 05 20:30:46 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords PMVK gene
Porokeratosis
Variation
Phosphomevalonate kinase
Mevalonate pathway
Language English
License This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission.
2023 The Author(s). Published by S. Karger AG, Basel.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c396t-c4d4d424c9380f56f59aa800480ca158d1df28ee69ab9a60ed666ce5a67127863
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
content type line 23
ORCID 0000-0002-0795-0397
OpenAccessLink https://karger.com/doi/10.1159/000531120
PMID 37315547
PQID 2826216331
PQPubID 23479
PageCount 8
ParticipantIDs crossref_primary_10_1159_000531120
gale_infotracacademiconefile_A777623903
pubmed_primary_37315547
karger_primary_531120
gale_infotracmisc_A777623903
proquest_miscellaneous_2826216331
PublicationCentury 2000
PublicationDate 2023-01-01
PublicationDateYYYYMMDD 2023-01-01
PublicationDate_xml – month: 01
  year: 2023
  text: 2023-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Switzerland
PublicationTitle Human heredity
PublicationTitleAlternate Hum Hered
PublicationYear 2023
Publisher S. Karger AG
Publisher_xml – name: S. Karger AG
References Song NJ, Luan J, Zhang ZH. Updating and identifying a novel mutation in the PMVK gene in classic porokeratosis of Mibelli. Clin Exp Dermatol. 2017;42(8):910–1.
Shi WH, Fu XA, Wang ZZ, Mi ZH, Zhang H, Yu GQ. Twenty-two novel mutations in a Chinese cohort of 137 patients with porokeratosis were identified using microfluidics (Fluidigm). J Dermatol Sci. 2021;101(1):75–7.
Tee SI, Chong WS. Eruptive pruritic papular porokeratosis. Indian J Dermatol Venereol Leprol. 2012;78(6):758–60.
Kanitakis J. Porokeratoses: an update of clinical, aetiopathogenic and therapeutic features. Eur J Dermatol. 2014;24(5):533–44.
Chambliss KL, Slaughter CA, Schreiner R, Hoffmann GF, Gibson KM. Molecular cloning of human phosphomevalonate kinase and identification of a consensus peroxisomal targeting sequence. J Biol Chem. 1996;271(29):17330–4.
Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 201240Database issueD10914.
Leng YJ, Yan LL, Feng HQ, Chen C, Wang SS, Luo Y. Mutations in mevalonate pathway genes in patients with familial or sporadic porokeratosis. J Dermatol. 2018;45(7):862–6.
Jägle S, Juratli HA, Hickman G, Süssmuth K, Boente MC, Kopp J. Porokeratosis Plantaris, Palmaris et Disseminata caused by con- genital pathogenic variants in the MVD gene and loss of hetero-zygosity in affected skin. Acta Derm Venereol. 20211012adv00397.
McGuigan K, Shurman D, Campanelli C, Lee JB. Porokeratosis ptychotropica: a clinically distinct variant of porokeratosis. J Am Acad Dermatol. 2009;60(3):501–3.
Liu Y, Wang JX, Qin YY, Huang CZ, Archacki S, Ma JJ. Identification of three mutations in the MVK gene in six patients associated with disseminated superficial actinic porokeratosis. Clin Chim Acta. 2016;454:124–9.
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and Genomics and the association for molecular pathology. Genet Med. 2015;17(5):405–24.
Li M, Li Z, Wang J, Ni C, Sun Z, Wilson NJ. Mutations in the mevalonate pathway genes in Chinese patients with porokeratosis. J Eur Acad Dermatol Venereol. 2016;30(9):1512–7.
Rahbari H, Cordero AA, Mehregan AH. Punctate porokeratosis. A clinical variant of porokeratosis of Mibelli. J Cutan Pathol. 1977;4(6):338–41.
Ferreira FR, Santos LD, Tagliarini FA, Lira ML. Porokeratosis of Mibelli--literature review and a case report. An Bras Dermatol. 2013886 Suppl 117982.
Wang JX, Liu Y, Liu F, Huang CZ, Han SS, Lv YX. Loss-of-function mutation in PMVK causes autosomal dominant disseminated superficial porokeratosis. Sci Rep. 2016;6:24226.
Atzmony L, Khan HM, Lim YH, Paller AS, Levinsohn JL, Holland KE. Second-hit, postzygotic PMVK and MVD mutations in linear porokeratosis. JAMA Dermatol. 2019;155(5):548–55.
Chang Q, Yan XX, Gu SY, Liu JF, Liang DC. Crystal structure of human phosphomevalonate kinase at 1.8 A resolution. Proteins. 2008;73(1):254–8.
Sertznig P, von Felbert V, Megahed M. Porokeratosis: present concepts. J Eur Acad Dermatol Venereol. 2012;26(4):404–12.
Allegra F. The man behind the eponym. Vittorio Mibelli and the tale of “porokeratosis”. Am J Dermatopathol. 1986;8(2):169–72.
Anderson DE, Chernosky ME. Disseminated superficial actinic porokeratosis. Genetic aspects. Arch Dermatol. 1969;99(4):408–12.
Commens CA, Shumack SP. Linear porokeratosis in two families with disseminated superficial actinic porokeratosis. Pediatr Dermatol. 1987;4(3):209–14.
Brasch J, Scheuer B, Christophers E. Porokeratosis plantaris, palmaris et disseminata. Hautarzt. 1985;36(8):459–61.
Olivier LM, Chambliss KL, Gibson KM, Krisans SK. Characterization of phosphomevalonate kinase: chromosomal localization, regulation, and subcellular targeting. J Lipid Res. 1999;40(4):672–9.
Zhang ZH, Li CH, Wu F, Ma RX, Luan J, Yang F. Genomic variations of the mevalonate pathway in porokeratosis. Elife. 2015;4:e06322.
References_xml
SSID ssj0008073
Score 2.37375
Snippet Background: Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes,...
Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including...
SourceID proquest
gale
crossref
pubmed
karger
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 50
SubjectTerms Amino acids
Analysis
Brief Report
DNA sequencing
Enzymes
Ethylenediaminetetraacetic acid
Genetic aspects
Humans
Hydrogen
Mutation
Mutation, Missense
Nucleotide sequencing
Pedigree
Phosphotransferases (Phosphate Group Acceptor) - genetics
Porokeratosis - genetics
Skin
Skin diseases
Title A Novel PMVK Variant Associated with Familial Porokeratosis
URI https://karger.com/doi/10.1159/000531120
https://www.ncbi.nlm.nih.gov/pubmed/37315547
https://www.proquest.com/docview/2826216331
Volume 88
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3da9swED_adC15KV3brV7ToI3BngyWZX3Rp6ykhI2EMNaSN6NIMpSOuCTpoP99T_6CFIrfLFkHd2fd_fTxO4DvRmaq8JmNuVzyOLOaxoZahSjFMy6tdKri7pzOxOQu-7Xgi2a9I9yFeQznnytq1I5bAANuVXqOYWqA4PwglSILMGsax92cq5JmLxnBMaYoacMhtPNpH46YZCF-yp0g1EzFH2rR72eaVcS5PYHjJlUko9q2H2HPr07hsC4e-XIKR9NmW_wMrkdkVv73_8h8ev-b3CP8RX2RVvPekbDaSqoaF-huZF6uy8dAplxuHjbncHc7_nsziZuqCLFlWmxjmzl8UlQrU0nBRcG1Maq6G24N5cpRV6TKe6HNUhuReIcIxXpuhKSpVIJ9gt6qXPkLIIhWXGoKiQ02o0ortaSJoz4xUlutdATfWjXlTzX5RV6BBq7zTq0R_AgKzMMPsV0ba5pz_SgiUEvlIylxwmU6YREMdnqiI9ud5vPaBJ2sVsDgzfvJZFw35U-uiOBra7A8jBgOja18-bzJEU2KFPNNRiP4XFuyG6L1hC_vCL2EfigsXy-2DKC3XT_7K0w_tssh7MuFHMLBz_Fs_mdY-eErBULPOg
link.rule.ids 315,783,787,27647,27936,27937,31732,33757
linkProvider Karger AG
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+Novel+PMVK+Variant+Associated+with+Familial+Porokeratosis&rft.jtitle=Human+heredity&rft.au=Zhang%2C+Wenjing&rft.au=Nie%2C+Xinmiao&rft.au=Shi%2C+Lei&rft.au=Shao%2C+Fengmin&rft.date=2023-01-01&rft.pub=S.+Karger+AG&rft.issn=0001-5652&rft.eissn=1423-0062&rft.volume=88&rft.issue=1&rft.spage=50&rft_id=info:doi/10.1159%2F000531120&rft.externalDocID=A777623903
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0001-5652&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0001-5652&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0001-5652&client=summon